Navigation Links
Side Effects in Statin Users Linked to Gene Mutation
Date:10/14/2009

Finding may help tailor treatments to keep patients from stopping meds, researcher says

WEDNESDAY, Oct. 14 (HealthDay News) -- U.S. researchers have identified a common gene mutation linked to side effects in people taking cholesterol-lowering statin drugs.

Statins can reduce high cholesterol and lower the risk of heart attack or stroke. But 25 percent to 50 percent of people prescribed the potentially lifesaving drugs stop taking them after a year because of side effects, in particular muscle aches.

The study included 509 people taking one of three types of statins: atorvastatin (Lipitor), simvastatin (Zocor) or pravastatin (Pravachol). The patients took the drugs for an initial period of eight weeks and then had their doses increased for an additional eight weeks.

The Duke University Medical Center researchers found that people with the common mutation in the SLCO1B1 gene were more likely to have muscle aches. The more copies of the mutation, the greater their risk.

The study also found that the muscle side effects differed depending on the type of statin. People taking simvastatin reported the most side effects while those taking pravastatin had the least muscle aches.

The findings, published online Oct. 12 in the Journal of the American College of Cardiology, may help doctors increase the number of patients who keep taking the drugs.

"If a genetic test can be developed to determine who will experience side effects that will likely make patients go off their medication, we can target these individuals for counseling about common side effects, monitor them more closely or tailor their medication accordingly," lead author and cardiologist Dr. Deepak Voora said in a Duke news release.

More information

The U.S. Food and Drug Administration has more about statins.



-- Robert Preidt



SOURCE: Duke Medicine, news release, Oct. 12, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Beneficial effects of alcohol?
2. News brief: Effects of aspirin and folic acid on inflammation markers for colorectal adenomas
3. GTRI is developing protocols for testing effects of RFID systems on medical devices
4. Smoking bans effects on heart disease risks -- IOM report releases Oct. 15
5. Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women
6. Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery
7. Penn studies point to strategies for reducing painful breast cancer drug side effects
8. Many Kids Suffer Medication Side Effects: Study
9. After-Effects of Chemotherapy May Include Memory Problems
10. Treating Childhood Leukemia With Fewer Side Effects
11. Yeast unravels effects of chemotherapy drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: